Asendan aort dilatasyonunda oksidatif stres ile ilişkili belirteçlerin rolü: malondialdehit ve paraoksonaz-1 aktivitesi
Open Access
- 29 January 2022
- journal article
- research article
- Published by Anadolu Klinigi Tip Bilimleri Dergisi in Anadolu Kliniği Tıp Bilimleri Dergisi
- Vol. 27 (1) , 1-8
Abstract
Background: This study aims to evaluate the antioxidative and oxidative status in patients with ascending aortic dilatation using malondialdehyde, an oxidative stress marker, and paraoxonase-1 activity, an antioxidant enzyme. Methods: This cross-sectional study included 56 consecutive patients (with mean age of 55.3±8.6 years; range, 31 to 67 years; 26 males, 30 females) with ascending aortic dilatation and 33 sex and age matched controls (13 males, 20 females). The mean age of the patients was 54.5±10.5 years old, with their age ranging from 32 to 67 years) with normal aortic diameters between August 2020 and December 2020. All patients were evaluated using transthoracic echocardiography. The paraoxonase-1 activity was measured manually using a spectrophotometer. The malondialdehyde was analyzed using the thiobarbituric acid assay. The relation of the ascending aortic dilatation with the malondialdehyde levels and paraoxonase-1 activity was identified with correlation analyses. Results: The patient group had significantly higher mean malondialdehyde than the control group (2.5±1.9 µmoL/mL vs.1.7±0.3 µmoL/mL, respectively; p<0.001). The patient group had significantly lower mean activity of paraoxonase-1 than the control group (18.5±12.9 U/mL vs.30±17.6 U/mL, respectively; p<0.002). The serum malondialdehyde was negatively correlated with ascending aortic diameter (r=0.293, p=0.009). A significant negative correlation was between the activity of serum paraoxonase-1 and ascending aortic diameter (r=-0.364, p=0.001). Malondialdehyde levels and paraoxonase-1 activity were the independent predictors of ascending aortic dilatation. Conclusion: study's results are in line with the notion that increased malondialdehyde levels indicating lipid peroxidation and decreased paraoxonase-1 activity indicating impaired antioxidant defense may be effective in protecting against the pathophysiology of ascending aortic dilatation. Amaç: Bu çalışmada, oksidatif stres belirteci malondialdehit ve antioksidan enzim paraoksonaz-1 aktivitesi ile asendan aort dilatasyonu olan hastalarda oksidatif ve antioksidatif durum değerlendirildi. Çalışma planı: Bu kesitsel çalışmaya Ağustos 2020-Aralık 2020 tarihleri arasında asendan aort dilatasyonu olan toplam 56 ardışık hasta (26 erkek, 30 kadın; ort. yaş: 55.3±8.6 yıl; dağılım, 31-67 yıl) ve aort çapı normal olan, yaş ve cinsiyet açısından eşleştirilmiş 33 kontrol (13 erkek, 20 kadın; ort. yaş: 54.5±10.5 yıl; dağılım, 32-67 yıl) dahil edildi. Hastaların tümü transtorasik ekokardiyografi ile değerlendirildi. Paraoksonaz-1 aktivitesi spektrofotometre ile manuel olarak ölçüldü. Malondialdehit, tiyobarbitürik asit testi ile ölçüldü. Asendan aort dilatasyonunun malondialdehit ve paraoksonaz-1 aktivitesi ile olan ilişkisini tespit etmek için korelasyon analizleri yapıldı. Bulgular: Ortalama malondialdehit düzeyleri, kontrol grubuna kıyasla, hasta grubunda anlamlı düzeyde daha yüksek idi (sırasıyla 1.7±0.3 µmoL/mL’ye kıyasla 2.5±1.9 µmoL/mL; p<0.001). Ortalama paraoksonaz-1 aktivitesi, hasta grubunda anlamlı düzeyde daha düşük idi (sırasıyla 30±17.6 U/mL’ye kıyasla 18.5±12.9 U/mL; p<0.002). Serum malondialdehit düzeyleri ve asendan aort çapı arasında pozitif, anlamlı bir ilişki saptandı (r=0.293, p=0.009). Serum paraoksonaz-1 aktivitesi ve asendan aort çapı arasında negatif, anlamlı bir ilişki saptandı (r=-0.364, p=0.001). Malondialdehit düzeyleri ve paraoksonaz-1 aktivitesi, asendan aort dilatasyonunun bağımsız ön gördürücüleri idi. Sonuç: Çalışma sonuçlarımız, lipid peroksidasyonunu gösteren artmış malondialdehit düzeylerinin ve bozulmuş antioksidan savunmasını gösteren azalmış paraoksonaz-1 aktivitesinin, asendan aort dilatasyonunun patofizyolojisinde rol oynayabileceği görüşünü desteklemektedir.Keywords
This publication has 25 references indexed in Scilit:
- Genistein as a potential inducer of the anti‐atherogenic enzyme paraoxonase‐1: studies in cultured hepatocytesin vitroand in rat liverin vivoJournal of Cellular and Molecular Medicine, 2012
- Molecular mechanisms of vascular effects of High‐density lipoprotein: alterations in cardiovascular diseaseEMBO Molecular Medicine, 2012
- What Is New in Dilatation of the Ascending Aorta?Circulation, 2011
- Basal and Oxidative Stress–Induced Expression of Metallothionein Is Decreased in Ascending Aortic Aneurysms of Bicuspid Aortic Valve PatientsCirculation, 2009
- Characterization of the inflammatory cells in ascending thoracic aortic aneurysms in patients with Marfan syndrome, familial thoracic aortic aneurysms, and sporadic aneurysmsThe Journal of Thoracic and Cardiovascular Surgery, 2008
- Paraoxonase-2 Reduces Oxidative Stress in Vascular Cells and Decreases Endoplasmic Reticulum Stress–Induced Caspase ActivationCirculation, 2007
- The oxidized phospholipids POVPC and PGPC inhibit growth and induce apoptosis in vascular smooth muscle cellsBiochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, 2006
- Very low density lipoproteins provide a vector for secretion of paraoxonase-1 from cellsAtherosclerosis, 2005
- Paraoxonase polymorphisms are not associated with cardiovascular risk in renal transplant recipientsKidney International, 1999
- Echocardiographic assessment of left ventricular hypertrophy: Comparison to necropsy findingsThe American Journal of Cardiology, 1986